1. Home
  2. BIO vs BWXT Comparison

BIO vs BWXT Comparison

Compare BIO & BWXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • BWXT
  • Stock Information
  • Founded
  • BIO 1952
  • BWXT 1867
  • Country
  • BIO United States
  • BWXT United States
  • Employees
  • BIO N/A
  • BWXT N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • BWXT
  • Sector
  • BIO Industrials
  • BWXT
  • Exchange
  • BIO Nasdaq
  • BWXT Nasdaq
  • Market Cap
  • BIO 6.0B
  • BWXT 12.8B
  • IPO Year
  • BIO N/A
  • BWXT N/A
  • Fundamental
  • Price
  • BIO $251.56
  • BWXT $142.46
  • Analyst Decision
  • BIO Strong Buy
  • BWXT Buy
  • Analyst Count
  • BIO 4
  • BWXT 9
  • Target Price
  • BIO $324.25
  • BWXT $136.33
  • AVG Volume (30 Days)
  • BIO 406.1K
  • BWXT 1.5M
  • Earning Date
  • BIO 07-31-2025
  • BWXT 08-04-2025
  • Dividend Yield
  • BIO N/A
  • BWXT 0.70%
  • EPS Growth
  • BIO N/A
  • BWXT 13.77
  • EPS
  • BIO N/A
  • BWXT 3.14
  • Revenue
  • BIO $2,541,100,000.00
  • BWXT $2,781,946,000.00
  • Revenue This Year
  • BIO N/A
  • BWXT $15.44
  • Revenue Next Year
  • BIO $3.49
  • BWXT $9.29
  • P/E Ratio
  • BIO N/A
  • BWXT $45.51
  • Revenue Growth
  • BIO N/A
  • BWXT 9.88
  • 52 Week Low
  • BIO $211.43
  • BWXT $84.21
  • 52 Week High
  • BIO $387.99
  • BWXT $145.33
  • Technical
  • Relative Strength Index (RSI)
  • BIO 65.86
  • BWXT 69.35
  • Support Level
  • BIO $237.42
  • BWXT $137.94
  • Resistance Level
  • BIO $254.82
  • BWXT $144.75
  • Average True Range (ATR)
  • BIO 7.14
  • BWXT 3.71
  • MACD
  • BIO 2.35
  • BWXT -0.91
  • Stochastic Oscillator
  • BIO 89.82
  • BWXT 56.17

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales primarily in the United States, Canada, and other regions.

Share on Social Networks: